Fertility Challenges Treatment How Down-Regulation Is Used to Ensure IVF Success Process Increases the Production of Viable Eggs By Rachel Gurevich, RN Rachel Gurevich, RN Facebook LinkedIn Twitter Rachel Gurevich is a fertility advocate, author, and recipient of The Hope Award for Achievement, from Resolve: The National Infertility Association. Learn about our editorial process Updated on February 03, 2020 Medically reviewed by Leyla Bilali, RN Medically reviewed by Leyla Bilali, RN Leyla Bilali, RN is a registered nurse, fertility nurse, and fertility consultant in the New York City area. She works in house at a reputable private clinic in New York City while also seeing her own clients through her concierge fertility consulting and nursing services business. Learn about our Medical Review Board Print VOISIN / PHANIE / Getty Images Table of Contents View All Table of Contents Why It's Used Long vs. Short IVF Protocol Drugs Used for Down-Regulation Alternate Techniques Down-regulation is a term that scientists use to describe the process of reducing or suppressing the body's response to specific stimuli. When used with regard to in vitro fertilization (IVF), down-regulation essentially "turns off" the ovaries to better control ovulation and egg maturation during treatment. There are two types of drugs used for this purpose: GnRH agonists and GnRH antagonists. An agonist is a type of drug that stimulates a response; an antagonist is a type that blocks a response. While the mechanisms of action for the two drugs differ, they both work by suppressing the body's production of various hormones that trigger egg development and ovulation. In this way, they down-regulate the physiological function of the ovaries. Why Down-Regulation Is Used Your ovaries contain thousands of follicles. Each follicle contains an immature egg, or oocyte. At the start of your cycle, luteinizing hormone (LH) and follicle-stimulating hormone (FSH) trigger the maturation process in a group of competing follicles. As the follicles begin to grow in size, they will release other hormones to regulate the flow of LH and FSH—sometimes up, sometimes down—until ovulation finally occurs. Ovulation usually involves only one egg. After that egg is released, all other follicles in that group wither and die. With IVF, your doctor doesn't want this to happen. Instead, the aim would be to down-regulate the response so that: Multiple follicles are able to produce a viable, mature egg.The eggs remain in the follicles so that they can be easily harvested. Long vs. Short IVF Protocol You may have also heard the terms "long protocol" and "short protocol." These describe two different approaches to down-regulation. As the names imply, the difference between these two approaches is the length of time down-regulation is imposed on the body. Long Protocol With the long protocol, down-regulation is started in the cycle before IVF treatment takes place. It may begin on day one or two of the cycle before, or it may not start until the mid-luteal phase, which is about one week post-ovulation (around day 21 of a 28-day cycle). Medications known as gonadotropin-releasing hormone agonists are used during a long protocol down-regulation, the most common one being Lupron. Birth control pills may also be taken the cycle or two before treatment as well. Long IVF protocols require more days of medication and more injections, which means the cycle tends to be more expensive. Also, because your hormones are being down-regulated over more days, you’re more likely to experience side effects over a longer period of time. That said, for many people, the long IVF protocol offers the best chances for IVF success. This makes the additional days of treatment, side effects, and increased cost possibly worthwhile. Short Protocol In the short protocol, down-regulation is achieved quickly and usually doesn’t start until the start of the IVF cycle itself. The medications used for this are GnRH antagonists like Antagon, Ganirelix, and Orgalutran. The short protocol may be better for those who are poor responders and might be better for those who are at higher risk of developing ovarian hyperstimulation syndrome (OHSS). Because you’re taking medications for a shorter period of time, this also means lower costs and fewer days of side effects. On the other hand, the short protocol may lead to fewer follicles (and therefore fewer embryos). There are also some concerns that GnRH antagonists come with an increased risk of birth defects, though the risk is still relatively small. Drugs Used for Down-Regulation There are a number of drugs used in IVF for down-regulation, and they are broadly characterized as follows: GnRH agonists include such drugs as Lupron (leuprolide), Synarel (nafarelin), and Zoladex (goserelin). GnRH agonists mimic the naturally occurring hormone known as gonadotropin-releasing hormone (GnRH). This is the hormone that triggers increased production of FSH and LH. By flooding the body with "fake" GnRH, the ovaries become increasingly overwhelmed and eventually shut down the production of LH and FSH after around three weeks. GnRH antagonists include the drugs Antagon (ganirelix) and Cetrotide (cetrorelix). GnRH antagonists work by binding to the receptor on GnRH and blocking its ability to receive signals of any sort. By doing so, the production of FSH and LH are shut down almost immediately. After taking the GnRH drugs for several days or weeks, an ultrasound would be used to confirm that the uterine lining is thin and the eggs are ready to be harvested. Fertility drugs would then be administered to stimulate the ovaries, after which the eggs would be harvested under local anesthesia. Side Effects and Risks of Fertility Drugs Alternate Techniques While down-regulation is an effective means of desensitizing the ovaries during IVF, it doesn't work well for all people. This is especially true in people with low ovarian reserves (a significantly decreased number of eggs). Because there would be far fewer follicles to work with, GnRH drugs can sometimes work too well. Rather than desensitizing the ovaries, they might end up canceling the cycle altogether. For these people, there are alternate techniques fertility specialists will use to achieve down-regulation, such as: Adding additional hormones to the treatmentGiving GnRH drugs at lower doses or for fewer daysStarting and then stopping the GnRH injections at different stagesStarting birth control pills for a month prior to IVF and then skipping doses to temper the maturation and ovulation processStarting GnRH treatment much later than usual During this time, the doctor will use blood tests and ultrasound to assess and better regulate follicular development. A Word From Verywell Down-regulation can help to increase success rates for many people undergoing IVF, but it still doesn't work for everyone. Talk to your doctor to weigh your options and see if this might be a worthwhile procedure for your individual situation. IVF and Fertility Treatment Myths 5 Sources Verywell Family uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy. Kong H, Bu Z, Guo Y, et al. Efficacy and safety of in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) among patients with endometriosis after a shortened protocol of long-term pituitary downregulation. Med Sci Monit. 2019;25:4377–4383. doi:10.12659/MSM.916447 Holesh JE. Physiology, ovulation. National Center for Biotechnology Information, U.S. National Library of Medicine. Cota AM, Oliveira JB, Petersen CG, et al. GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology. Reprod Biol Endocrinol. 2012;10:33. doi:10.1186/1477-7827-10-33 Toftager M, Bogstad J, Bryndorf T, et al. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Hum Reprod. 2016;31(6):1253-64. doi:10.1093/humrep/dew051 Badawy A, Wageah A, El Gharib M, Osman EE. Strategies for pituitary down-regulation to optimize IVF/ICSI outcome in poor ovarian responders. J Reprod Infertil. 2012;13(3):124–130. Additional Reading Magon N. Gonadotropin-releasing hormone agonists: Expanding vistas. Ind J Endocrinol Metab. 2011;15(4):261-7. doi:10.4103/2230-8210.85575. Shrestha D, La X, Feng HL. Comparison of different stimulation protocols used in in vitro fertilization: a review. Ann Transl Med. 2015;3(10):137. doi:10.3978/j.issn.2305-5839.2015.04.09. By Rachel Gurevich, RN Rachel Gurevich is a fertility advocate, author, and recipient of The Hope Award for Achievement, from Resolve: The National Infertility Association. She is a professional member of the Association of Health Care Journalists and has been writing about women’s health since 2001. Rachel uses her own experiences with infertility to write compassionate, practical, and supportive articles. See Our Editorial Process Meet Our Review Board Share Feedback Was this page helpful? Thanks for your feedback! What is your feedback? Other Helpful Report an Error Submit